{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:41:06Z","timestamp":1792478466814,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.pnpbp.2025.111349","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T18:53:17Z","timestamp":1743965597000},"page":"111349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Impact of antipsychotics on prolactin levels in youth with psychiatric disorders: A cross-sectional study"],"prefix":"10.1016","volume":"138","author":[{"given":"Shuhei","family":"Wada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiro","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Yoshimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotake","family":"Hida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Hotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiro","family":"Noda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2025.111349_bb0005","article-title":"Hyperprolactinemia in adults treated with anti-psychotic drugs attending tertiary hospitals in Oman: an observational study","volume":"14","author":"Al Harthi","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.pnpbp.2025.111349_bb0010","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1080\/13651501.2018.1425459","article-title":"Prevalence and risk factors of hyperprolactinemia among patients with various psychiatric diagnoses and medications","volume":"22","author":"Alosaimi","year":"2018","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0015","first-page":"25","article-title":"Antipsychotic prescription in children and adolescents: an analysis of data from a German statutory health insurance company from 2005 to 2012","volume":"111","author":"Bachmann","year":"2014","journal-title":"Dtsch. Arztebl. Int."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0020","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/archdischild-2014-307224","article-title":"Drug use in French children: a population-based study","volume":"100","author":"Benard-Laribiere","year":"2015","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0025","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12888-023-04598-y","article-title":"Effectiveness and safety of blonanserin in young and middle-aged female patients with schizophrenia: data from a post-marketing surveillance","volume":"23","author":"Bo","year":"2023","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111349_bb0030","article-title":"Review of the safety of second-generation antipsychotics: Are they really \u201catypically\u201d safe for youth and adults?","volume":"14","author":"Briles","year":"2012","journal-title":"Prim. Care Companion CNS Disord."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0035","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1177\/2045125313487548","article-title":"Possible mechanisms for the skeletal effects of antipsychotics in children and adolescents","volume":"3","author":"Calarge","year":"2013","journal-title":"Therap. Adv. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0040","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1186\/s12888-023-05240-7","article-title":"Efficacy and safety of blonanserin versus risperidone in the treatment of schizophrenia: a systematic review and meta-analysis of randomized controlled trials","volume":"23","author":"Deng","year":"2023","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111349_bb0045","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000326697","article-title":"Eating disorders throughout female adolescence","volume":"22","author":"Domin\u00e9","year":"2012","journal-title":"Endocr. Dev."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0050","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1024\/1422-4917\/a000505","article-title":"Non-adherence to psychotropic medication among adolescents - a systematic review of the literature","volume":"46","author":"Hage","year":"2018","journal-title":"Z. Kinder Jugendpsychiatr. Psychother."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0055","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.euroneuro.2017.07.001","article-title":"International trends in antipsychotic use: a study in 16 countries, 2005-2014","volume":"27","author":"Halfdanarson","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0060","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2265.2010.03814.x","article-title":"Antipsychotics and hyperprolactinaemia: mechanisms, consequences and management","volume":"74","author":"Holt","year":"2011","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.pnpbp.2025.111349_bb0065","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/10398562231158925","article-title":"Association between long-term use of prolactin-elevating antipsychotics in women and the risk of breast cancer: what are the clinical implications?","volume":"31","author":"Hope","year":"2023","journal-title":"Australas. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111349_bb0070","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.2174\/1570159X21666221027143920","article-title":"Sex differences in serum prolactin levels in children and adolescents on antipsychotics: a systematic review and meta-analysis","volume":"21","author":"Ilzarbe","year":"2023","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0075","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/JCP.0000000000000979","article-title":"Effect ofbrexpiprazole on prolactin: an analysis of short- and long-term studies in schizophrenia","volume":"39","author":"Ivkovic","year":"2019","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0080","first-page":"1","article-title":"Risk of adverse events associated with domperidone and metoclopramide in gastroparesis: systematic review and meta-analysis","volume":"23","author":"Junqueira","year":"2023","journal-title":"Drugs R D."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0085","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pnpbp.2011.11.016","article-title":"Sexual dysfunction and hyperprolactinemia in Japanese schizophrenic patients taking antipsychotics","volume":"37","author":"Kikuchi","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111349_bb0090","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/npr2.12180","article-title":"Discovery research and development history of the dopamine D(2) receptor partial agonists, aripiprazole and brexpiprazole","volume":"41","author":"Kikuchi","year":"2021","journal-title":"Neuropsychopharmacol. Rep."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0095","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jaac.2023.03.007","article-title":"Antipsychotic-related prolactin levels and sexual dysfunction in mentally ill youth: a 3-month cohort study","volume":"62","author":"Koch","year":"2023","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111349_bb0100","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/fcp.12553","article-title":"Prescription patterns of first- and second-generation antipsychotic drugs in the French population","volume":"34","author":"Kovess-Masfety","year":"2020","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0105","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.euroneuro.2018.03.008","article-title":"Efficacy, acceptability, and tolerability of antipsychotics in children and adolescents with schizophrenia: a network meta-analysis","volume":"28","author":"Krause","year":"2018","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0110","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1089\/cap.2021.0140","article-title":"A meta-analysis of antipsychotic-induced hypo- and hyperprolactinemia in children and adolescents","volume":"32","author":"Kroigaard","year":"2022","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0115","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jclinepi.2021.01.008","article-title":"Framework for the treatment and reporting of missing data in observational studies: the Treatment And Reporting of Missing data in Observational Studies framework","volume":"134","author":"Lee","year":"2021","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0120","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00004714-198806000-00008","article-title":"Haloperidol and prolactin concentrations in Asians and Caucasians","volume":"8","author":"Lin","year":"1988","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0125","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.tem.2020.01.004","article-title":"Time for a new perspective on prolactin in metabolism","volume":"31","author":"Macotela","year":"2020","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0130","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/hup.1116","article-title":"Hyperprolactinemia associated with psychotropics--a review","volume":"25","author":"Madhusoodanan","year":"2010","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0135","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/YIC.0000000000000063","article-title":"Prolactin variations during risperidone therapy in a sample of drug-naive children and adolescents","volume":"30","author":"Margari","year":"2015","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0140","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.jaac.2013.02.008","article-title":"Practice parameter for the assessment and treatment of children and adolescents with schizophrenia","volume":"52","author":"Mcclellan","year":"2013","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111349_bb0145","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2125.1987.tb03153.x","article-title":"Prolactin response to low dose sulpiride","volume":"24","author":"McMurdo","year":"1987","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0150","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-058940","article-title":"Clarity and applicability of adverse drug reaction-related monitoring instructions in clinical practice guidelines for children and adolescents treated with antipsychotic drugs: a review of six clinical practice guidelines","volume":"12","author":"Minjon","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.pnpbp.2025.111349_bb0155","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/MPG.0000000000000657","article-title":"Prokinetics prescribing in paediatrics: evidence on cisapride, domperidone, and metoclopramide","volume":"60","author":"Mt-Isa","year":"2015","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0160","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12991-021-00361-3","article-title":"Long-term oral blonanserin treatment for schizophrenia: a review of Japanese long-term studies","volume":"20","author":"Murasaki","year":"2021","journal-title":"Ann. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111349_bb0165","first-page":"30","article-title":"Brexpiprazole as a new serotonin-dopamine receptor modulator: considering the clinical relevance for metabolic parameters and prolactin levels","volume":"16","author":"Nakamura","year":"2019","journal-title":"Innov. Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0170","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jadohealth.2019.08.032","article-title":"What are the effects of restrictive eating disorders on growth and puberty and are effects permanent? A systematic review and meta-analysis","volume":"66","author":"Neale","year":"2020","journal-title":"J. Adolesc. Health"},{"key":"10.1016\/j.pnpbp.2025.111349_bb0175","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-3260","article-title":"Antiemetics in children with acute gastroenteritis: a meta-analysis","volume":"145","author":"Ni\u00f1o-Serna","year":"2020","journal-title":"Pediatrics"},{"key":"10.1016\/j.pnpbp.2025.111349_bb0180","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jadohealth.2016.05.001","article-title":"A longitudinal study of problems in sexual functioning and related sexual distress among middle to late adolescents","volume":"59","author":"O\u2019Sullivan","year":"2016","journal-title":"J. Adolesc. Health"},{"key":"10.1016\/j.pnpbp.2025.111349_bb0185","article-title":"Antipsychotic-induced sexual dysfunction and its management","volume":"30","author":"Park","year":"2012","journal-title":"World J. Men\u2019s Health."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1015520","article-title":"Metabolic effects of prolactin","volume":"13","author":"Pirchio","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0195","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/pch\/16.9.581","article-title":"Evidence-based recommendations for monitoring safety of second-generation antipsychotics in children and youth","volume":"16","author":"Pringsheim","year":"2011","journal-title":"Paediat. Child Health."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0200","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S2215-0366(22)00404-7","article-title":"Trends in antipsychotic prescribing to children and adolescents in England: cohort study using 2000\u201319 primary care data","volume":"10","author":"Radoj\u010di\u0107","year":"2023","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111349_bb0205","first-page":"853","article-title":"Antidepressant use and circulating prolactin levels","volume":"27","author":"Reeves","year":"2016","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.pnpbp.2025.111349_bb0210","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/archdischild-2015-308428","article-title":"Do we prescribe medicines rationally?","volume":"100","author":"Rieder","year":"2015","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0215","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1089\/cap.2008.0120","article-title":"Antipsychotic medication in children and adolescents: a descriptive review of the effects on prolactin level and associated side effects","volume":"19","author":"Roke","year":"2009","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0220","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1192\/bja.2020.36","article-title":"Hyperprolactinaemia in the context of psychiatry","volume":"27","author":"Romain","year":"2020","journal-title":"BJPsych Adv."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0225","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1089\/cap.2012.0062","article-title":"Prolactin serum concentrations during aripiprazole treatment in youth","volume":"23","author":"Safer","year":"2013","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0230","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1089\/cap.2021.0058","article-title":"Long-term safety and efficacy of blonanserin oral tablet in adolescents with schizophrenia: a 52-week, multicenter, open-label extension study","volume":"32","author":"Saito","year":"2022","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0235","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1089\/cap.2021.0013","article-title":"Efficacy and safety of blonanserin oral tablet in adolescents with schizophrenia: a 6-week, randomized placebo-controlled study","volume":"32","author":"Saito","year":"2022","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0240","first-page":"2133","article-title":"Antipsychotics-related hyperprolactinaemia among patients with schizophrenia in Maiduguri","volume":"30","author":"Shettima","year":"2024","journal-title":"S. Afr. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111349_bb0245","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/JCP.0000000000000527","article-title":"Aripiprazole-associated hypoprolactinemia in the clinical setting","volume":"36","author":"Sogawa","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0250","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1093\/schbul\/sbae058","article-title":"Antipsychotic use and risk of breast cancer in women with severe mental illness: replication of a nationwide nested case-control database study","volume":"50","author":"Solmi","year":"2024","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0255","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jpsychires.2020.08.025","article-title":"Incidence, prevalence and prescription patterns of antipsychotic medications use in Asia and US: a cross-nation comparison with common data model","volume":"131","author":"Su","year":"2020","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0260","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/JCP.0000000000001158","article-title":"Lower prolactin levels in patients treated with aripiprazole regardless of antipsychotic monopharmacy or polypharmacy","volume":"40","author":"Sugai","year":"2020","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0265","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1479-828X.2011.01321.x","article-title":"Variation of female prolactin levels with menopausal status and phase of menstrual cycle","volume":"51","author":"Tanner","year":"2011","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0270","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2147\/NDT.S34433","article-title":"Profile of blonanserin for the treatment of schizophrenia","volume":"9","author":"Tenjin","year":"2013","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0275","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2036.2004.01867.x","article-title":"Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics","volume":"19","author":"Tonini","year":"2004","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0280","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3389\/fpsyt.2020.00316","article-title":"New users of antipsychotics among children and adolescents in 2008-2017: a nationwide register study","volume":"11","author":"Varimo","year":"2020","journal-title":"Front. Psych."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0285","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1210\/clinem\/dgac139","article-title":"Growth hormone and thyroid function in children with attention deficit hyperactivity disorder undergoing drug therapy","volume":"107","author":"Wang","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0290","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3389\/fphar.2020.00433","article-title":"Risks of sulpiride-induced parkinsonism in peptic ulcer and gastroesophageal reflux disease patients in Taiwan: a nationwide population-based study","volume":"11","author":"Wei","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0295","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/JCP.0b013e3181ee832d","article-title":"Dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia","volume":"30","author":"Yasui-Furukori","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2025.111349_bb0300","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00431-012-1894-2","article-title":"Off-label prescribing patterns of antiemetics in children: a multicenter study in Italy","volume":"172","author":"Zanon","year":"2013","journal-title":"Eur. J. Pediatr."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584625001034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584625001034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T11:36:17Z","timestamp":1754480177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584625001034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":60,"alternative-id":["S0278584625001034"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111349","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of antipsychotics on prolactin levels in youth with psychiatric disorders: A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111349","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111349"}}